Next, we functionally addressed the question, whether a shift to fully glycosylated TIMP-1glyc1/1 can be linked to noncanonic CD63-mediated tumor-promoting effects of TIMP-1, namely tumor cell proliferation and survival (23, 24). The gene discussed is CD63; the disease is neoplasm.